Literature DB >> 21316142

Recurrent versus isolated pre-eclampsia and risk of feto-infant morbidity outcomes: racial/ethnic disparity.

Alfred K Mbah1, Amina P Alio, Phillip J Marty, Karen Bruder, R Wilson, Hamisu M Salihu.   

Abstract

OBJECTIVE: We examined the association between recurrent versus isolated pre-eclampsia and feto-infant morbidity outcomes. STUDY
DESIGN: This is a population-based retrospective study on Florida hospital discharge data linked to the birth cohort files from 1998 through 2007. The study population comprised women with singleton first and second births who experienced pre-eclampsia in both pregnancies, and a comparison group consisting of women who were normotensive during their first pregnancy but developed pre-eclampsia in their second pregnancy. Feto-infant morbidities (low birth weight, very low birth weight, preterm, very preterm and small for gestational age) were the outcome of interest. Adjusted odds ratios (ORs) and 95% confidence intervals (CIs) for the association between recurrent pre-eclampsia and feto-infant morbidity outcomes were obtained from logistic regression models. RESULT: Women who experienced recurrent pre-eclampsia were at elevated risk for low birth weight, very low birth weight, preterm and very preterm. The risk was most pronounced for preterm infants (OR=1.58 CL=1.42-1.76). Subgroup analysis demonstrated that infants born to black mothers with recurrent pre-eclampsia experienced the most elevated risk across all the racial/ethnic subgroups and this was most pronounced for very low birth weight and very preterm with a more than three-fold increase in risk (OR=3.77, 95% CI=2.77-5.13 and OR=3.66, 95% CI=2.66-5.03, respectively) as compared to the referent category (white mothers who were normotensive in first pregnancy but developed pre-eclampsia in their second pregnancy).
CONCLUSION: Pre-eclampsia is very severe when it recurs and black women are affected more than white or Hispanic women.
Copyright © 2011 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21316142     DOI: 10.1016/j.ejogrb.2010.12.036

Source DB:  PubMed          Journal:  Eur J Obstet Gynecol Reprod Biol        ISSN: 0301-2115            Impact factor:   2.435


  7 in total

1.  Effectiveness of a federal healthy start program in reducing the impact of particulate air pollutants on feto-infant morbidity outcomes.

Authors:  Hamisu M Salihu; Euna M August; Alfred K Mbah; Amina P Alio; Raymond de Cuba; Foday M Jaward; Estrellita Lo Berry
Journal:  Matern Child Health J       Date:  2012-11

2.  Small size for gestational age and the risk for infant mortality in the subsequent pregnancy.

Authors:  Hamisu M Salihu; Abraham Salinas; Euna M August; Mulubrhan F Mogos; Hanna Weldeselasse; Valerie E Whiteman
Journal:  Ann Epidemiol       Date:  2012-08-02       Impact factor: 3.797

3.  Group B streptococcal colonization and the risk of pre-eclampsia.

Authors:  Z D Mulla; V Annavajjhala; J L Gonzalez-Sanchez; M R Simon; B S Nuwayhid
Journal:  Epidemiol Infect       Date:  2012-07-20       Impact factor: 4.434

4.  Pre-pregnancy cardiovascular risk factors and racial disparities in birth outcomes: the Bogalusa Heart Study.

Authors:  Emily W Harville; Leann Myers; Tian Shu; Maeve E Wallace; Lydia A Bazzano
Journal:  BMC Pregnancy Childbirth       Date:  2018-08-20       Impact factor: 3.007

5.  Adverse Outcomes of Preeclampsia in Previous and Subsequent Pregnancies and the Risk of Recurrence.

Authors:  Ulas Coban; Taha Takmaz; Ozge Deniz Unyeli; Savas Ozdemir
Journal:  Sisli Etfal Hastan Tip Bul       Date:  2021-09-24

6.  Recurrence of preeclampsia in northern Tanzania: a registry-based cohort study.

Authors:  Michael J Mahande; Anne K Daltveit; Blandina T Mmbaga; Gileard Masenga; Joseph Obure; Rachel Manongi; Rolv T Lie
Journal:  PLoS One       Date:  2013-11-01       Impact factor: 3.240

Review 7.  Pregnancy, parturition and preeclampsia in women of African ancestry.

Authors:  Annettee Nakimuli; Olympe Chazara; Josaphat Byamugisha; Alison M Elliott; Pontiano Kaleebu; Florence Mirembe; Ashley Moffett
Journal:  Am J Obstet Gynecol       Date:  2013-10-30       Impact factor: 8.661

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.